False-negative urine immunoassay after lorazepam overdose [3]

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 11, 2006, Pages 1600-1601

  Wenk, Robert E ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BETA GLUCURONIDASE; LANSOPRAZOLE; LORAZEPAM; OLMESARTAN;

ADULT; ANHEDONIA; ANTIGEN ANTIBODY COMPLEX; ANXIETY; AUTOANALYZER; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; COPING BEHAVIOR; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DILUTION; DRUG OVERDOSE; DUODENUM ULCER; EVALUATION; FALSE NEGATIVE RESULT; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPERTENSION; IMMUNOASSAY; LETTER; MASS SPECTROMETRY; QUANTITATIVE ASSAY; SCREENING TEST; SOCIAL ISOLATION; SUICIDE ATTEMPT; SYMPTOM; URINALYSIS;

ANTI-ANXIETY AGENTS; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOASSAY; LORAZEPAM; OVERDOSE; SUICIDE, ATTEMPTED;

EID: 33750597782     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Klette KL, Wiegand RF, Horn CK, Stout PR, Magluilo J. Urine benzodiazepine screening using Roche Online KIMS immunoassay with β-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry. J Analytical Toxicol. 2005;29(April):193-200.
2. DAT-9763 COBAS/INTEGRA 800 Training Manual, 2001 Rev, 14-9-14-10.